Inventor · disambiguated record
Michael Horstmann
Also filed as: HORSTMANN MICHAEL
56 granted patents·20 pending applications·1,432 citations·filing 1988–2019
99Inventor score
Files withLOHMANN THERAPIE SYST LTS27HORSTMANN MICHAEL12LTS LOHMANN THERAPIE SYSTEME AG11PURDUE PHARMA LP3HILLE THOMAS2
Top patents by PatentIndex Score
76 records- 0196US6521250B2Transdermal therapeutic system containing estradiolLOHMANN THERAPIE SYST LTS·Filed 2000·Granted Feb 18, 2003·166 cites·24 claims
- 0294US10881607B2Composition for transdermal delivery of cationic active agentsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Jan 5, 2021·7 cites·21 claims
- 0394US9717698B2Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracyLTS LOHMANN THERAPIE SYSTEME AG·Filed 2016·Granted Aug 1, 2017·13 cites·22 claims
- 0494US5629003ARapidly disintegrating sheet-like presentations of multiple dosage unitsLOHMANN THERAPIE SYST LTS·Filed 1994·Granted May 13, 1997·300 cites·7 claims
- 0593US6800329B2Method for producing film-type dosageLOHMANN THERAPIE SYST LTS·Filed 2002·Granted Oct 5, 2004·62 cites·12 claims
- 0693US5254348ATransdermal therapeutic system comprising tulobuterol as active substanceLOHMANN THERAPIE SYST LTS·Filed 1991·Granted Oct 19, 1993·119 cites·9 claims
- 0792US10881606B2Composition for transdermal delivery of cationic active agentsSCHMITZ CHRISTOPH·Filed 2009·Granted Jan 5, 2021·12 cites·28 claims
- 0892US9308202B2Transdermal therapeutic system for administering the active substance buprenorphineHILLE THOMAS·Filed 2007·Granted Apr 12, 2016·15 cites·20 claims
- 0992US5230898ATransdermal therapeutic system exhibiting an increased active substance flow and process for the production thereofLOHMANN THERAPIE SYST LTS·Filed 1990·Granted Jul 27, 1993·118 cites·13 claims
- 1091US8366600B2Polyamine enhanced formulations for triptan compound iontophoresisNUPATHE INC·Filed 2008·Granted Feb 5, 2013·9 cites·27 claims
- 1189US9089527B2Transdermal therapeutic system comprising ion pair microreservoirsHILLE THOMAS·Filed 2007·Granted Jul 28, 2015·7 cites·13 claims
- 1285US10292942B2Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient fluxHORSTMANN MICHAEL·Filed 2007·Granted May 21, 2019·3 cites·25 claims
- 1382US10307382B2Transdermal therapeutic system for 5-aminolevulinic acid hydrochlorideJUNG TOBIAS·Filed 2012·Granted Jun 4, 2019·9 cites·12 claims
- 1481US9056026B2Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracyHORSTMANN MICHAEL·Filed 2007·Granted Jun 16, 2015·3 cites·21 claims
- 1580US8980308B2Transdermal pharmaceutical preparation containing active substance combinations, for treating Parkinson's diseaseHORSTMANN MICHAEL·Filed 2004·Granted Mar 17, 2015·18 cites·11 claims
- 1679US5702721ATransdermal therapeutic system exhibiting an increased active substance flow and process for the production thereofLOHMANN THERAPIE SYST LTS·Filed 1994·Granted Dec 30, 1997·48 cites·21 claims
- 1776US8307983B2Non-reclosable package for products prejudicial to health, as well as process for its productionLUDWIG KARIN·Filed 2005·Granted Nov 13, 2012·8 cites·46 claims
- 1876US6623763B2Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organismLTS LOHMANN THERAPE SYSTEM AG·Filed 2001·Granted Sep 23, 2003·10 cites·13 claims
- 1976US5716636ATransdermal therapeutic system with acetylsalicylic acid in crystalline form as active substanceLOHMANN THERAPIE SYST LTS·Filed 1994·Granted Feb 10, 1998·33 cites·11 claims
- 2075US9114240B2Transdermal therapeutic system reinforced by ultrasoundsHORSTMANN MICHAEL·Filed 2007·Granted Aug 25, 2015·17 cites·28 claims
- 2175US8882729B2Transdermal therapeutic system having stabilized membraneHORSTMANN MICHAEL·Filed 2009·Granted Nov 11, 2014·2 cites·17 claims
- 2275US7560121B1Transdermal therapeutic system with a highly effective neuroleptic agentLOHMANN THERAPIE SYST LTS·Filed 2000·Granted Jul 14, 2009·8 cites·15 claims
- 2375US6143319ATransdermal therapeutic system containing estradiolLOHMANN THERAPIE SYST LTS·Filed 1997·Granted Nov 7, 2000·34 cites·24 claims
- 2475US5685837AGalvanically active transdermal therapeutic systemLTS LOHMANNTHERAPIE SYSTEME GM·Filed 1991·Granted Nov 11, 1997·166 cites·20 claims
- 2573US6316023B1TTS containing an antioxidantNOVARTIS AG·Filed 2000·Granted Nov 13, 2001·5 cites·9 claims
- 2672US9421174B2Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracyLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Aug 23, 2016·1 cites·22 claims
- 2771US6682756B1Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substanceLOHMANN THERAPIE SYST LTS·Filed 1997·Granted Jan 27, 2004·30 cites·10 claims
- 2871US4882163ATransdermal therapeutic systemBEIERSDORF AG·Filed 1988·Granted Nov 21, 1989·19 cites·8 claims
- 2970US8534461B2Non-reclosable package for products prejudicial to health, as well as process for its productionLOHMANN THERAPIE SYST LTS·Filed 2012·Granted Sep 17, 2013·2 cites·45 claims
- 3070US6074665ATransdermal therapeutic system for administering active agents to the human body via the skinLOHMANN THERAPIE SYST LTS·Filed 1996·Granted Jun 13, 2000·35 cites·8 claims
- 3169US6659442B1Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pileLTS LOHAMANN THERAPIE SYSTEME·Filed 1999·Granted Dec 9, 2003·17 cites·7 claims
- 3269US6335031B1TTS containing an antioxidantNOVARTIS AG·Filed 1999·Granted Jan 1, 2002·36 cites·20 claims
- 3368US10596126B2Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient fluxLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Mar 24, 2020·0 cites·18 claims
- 3467US7640816B2Monitoring system for collecting and/or transdermally rediffusing air containing environmental contaminants, and corresponding methodLOHMANN THERAPIE SYST LTS·Filed 2005·Granted Jan 5, 2010·3 cites·19 claims
- 3565US2019192506A1Transdermal therapeutic system for administering the active substance buprenorphineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 3663US2018289698A1Transdermal therapeutic system for administering the active substance buprenorphinePURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 3761US8883191B2Method for producing individually dosed active substance-containing and, in particular, aromatics-containing film-shaped administration forms rapidly disintegrating upon contact with liquidHORSTMANN MICHAEL·Filed 2003·Granted Nov 11, 2014·0 cites·15 claims
- 3860US2017224676A1Transdermal therapeutic system for administering the active substance buprenorphinePURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 3960US2019328680A1Transdermal Therapeutic System with a Low Tendency to Spontaneously CrystallizeUCB PHARMA GMBH·Filed 2019·Application pending·0 cites
- 4057US5902601AVolatile active substance containing plaster that may be produced without solventsLOHMANN THERAPIE SYST LTS·Filed 1997·Granted May 11, 1999·18 cites·15 claims
- 4157US2016175447A1Transdermal therapeutic system for administering the active substance buprenorphinePURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 4257US2014378917A1Transdermal therapeutic system with a low tendency to spontaneously crystallizeUCB PHARMA GMBH·Filed 2012·Application pending·0 cites
- 4357US2015190349A1Transdermal therapeutic systemHORSTMANN MICHAEL·Filed 2014·Application pending·0 cites
- 4456US11612571B2Transdermal therapeutic system for administering water-soluble peptides and polypeptidesASMUSSEN BODO·Filed 2008·Granted Mar 28, 2023·0 cites·15 claims
- 4556US11291745B2Water-vapor-permeable adhesive bandagesLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Apr 5, 2022·0 cites·11 claims
- 4654US10363228B2Transdermal administration of memantineEIFLER RENE·Filed 2011·Granted Jul 30, 2019·1 cites·23 claims
- 4752US2019240166A1Transdermal Therapeutic System for 5-Aminolevulinic Acid HydrochlorideLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 4852US2016199316A1Three-layer transdermal therapy system (tts)TESA LABTEC GMBH·Filed 2014·Application pending·0 cites
- 4951US5912008ATransdermal therapeutic system for the release of 17-β-estradiol and process for its productionLOHMANN THERAPIE SYST LTS·Filed 1997·Granted Jun 15, 1999·19 cites·9 claims
- 5050US10471021B2Transdermal therapeutic system for the administration of peptidesLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Nov 12, 2019·0 cites·20 claims
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Horstmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →